Download 

Cooperation Together for Production of COVID-19 Vaccines

Views:21     Author:Site Editor     Publish Time: 2021-02-05      Origin:Site

01

As the Chinese New Year approaches, the production of the COVID-19 vaccines is of great urgency, and its packaging needs to keep up with the pace in order to prevent the outbreak.


On December 31th, 2020, the first COVID-19 vaccine was approved to be marketed in China with conditions. A number of other COVID-19 vaccine have also been carried out phase III clinical trials in overseas countries, and the research and development of the vaccine has entered the sprint phase and is ready for mass production.

02

 

As a pharmaceutical packaging manufacturer, Sheng Zou Pharmaceutical Packaging & Device Technology (China) Co., Ltd. (hereinafter referred to as "ShengZou Group") uses ExxPro ™ special elastomers to produce rubber products, which have already registered and applied to the packaging of the COVID-19 vaccines, and are widely used in sterile powder, freeze-dried, injection, pre-filled syringe and other pharmaceutical packaging materials. Shengzou Group has entered into a long-term contract with ExxonMobil Chemical, the supplier of ExxPro special elastomer raw materials, by cooperating with ExxonMobil Chemicals providing a steady supply of consistent quality raw materials, to assist the packaging production of the COVID-19 vaccines.

 

03


Established in 1970, Shengzou Group has been engaged in pharmaceutical packaging materials for more than 51 years and has a number of subsidiaries producing pharmaceutical packaging materials related products. Current market demands include medicinal butyl rubber stoppers (for powder injection, freeze dried, fluid infusion, biological agent, oral liquid, etc.), and medical equipment-related rubber and plastic products like syringe plunger seals, IV injection discs.

 

04

Under the circumstance of the global epidemic of COVID-19 in 2020, Shengzou Group actively cooperated with many domestic pharmaceutical enterprises to assist the research and development of COVID-19 vaccines. In order to meet the requirements of high cleanliness and drug compatibility of the COVID-19 vaccine, Shengzou Group finally selected ExxPro speciality elastomers from ExxonMobil Chemical as the raw material of the rubber stoppers after analyzing the physical properties, chemical properties and product extracts, and was successfully authorized by its customer (Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd.) as the rubber stopper supplier of the COVID-19 vaccines. In other countries and regions outside China, such as Taiwan, Indonesia, and the USA, more than 8 pharmaceutical companies producing vaccines have cooperated with Shengzou Group, and currently the clinical trial phase II-III is being successively carried out.

 

ExxPro Speciality Elastomers and Brominated Butyl Rubber Stopper

Comparison Table of Physical Properties

05en

ExxPro Speciality Elastomers and Brominated Butyl Rubber Stopper


Analysis Results of Possible Extract in Six Extracts

06en

*Data ResourceR&D LAB of SHENGZOU GROUP

 

 

 

07

ExxonMobil Chemical's ExxPro Speciality Elastomers are ideal for bottle stoppers and seals, Ideal for sensitive drugs and other demanding applications, Exxpro specialty elastomers are a super-clean solution and cost-effective alternative to expensive coated stoppers, which can meet the increasingly strict pharmaceutical packaging requirements.

 


ExxPro speciality elastomers offer lower permeability, better ozone, chemical, weather and heat resistance, as well as superior stability against gamma irradiation.

08

09en

 

10


We, Shengzou Group, have been actively engaged in anti-COVID research and development. Through continuous innovation and even through the cooperation with ExxonMobil Chemical, our products passed the certification for the COVID-19 vaccines, we have made our modest efforts but also undertaken the social responsibility of the enterprise.

-------------    Mr.Zhushun Chao    President of Shengzou Group

 

10

Shengzou Group's innovative concept and social responsibility coincide with ours. We are glad that we can indirectly participate in the fight against the coronavirus and contribute through the excellent performance of the product. We will cooperate whole heartedly, and go forward together.

---------------  Mrs.Cuiqin Fan  Global Marketing Director

ExxonMobil Chemical Butyl Rubber & Elastomers Division

 

 

 

  • Product Name
  • Product Keyword
  • Product Model
  • Product Summary
  • Product Description
  • Multi Field Search
 2015 Shengzou Rubber&Plastics Co. Ltd

News

More >>
  • Feb
    05
    [2021] Cooperation Together for Production of COVID-19 Vaccines

    As the Chinese New Year approaches, the production of the COVID-19 vaccines is of great urgency, and its packaging needs to keep up with the pace in order to prevent the outbreak.On December 31th, 2020, the first COVID-19 vaccine was approved to be marketed in China with conditions. A number of other COVID-19 vaccine have also been carried out phase III clinical trials in overseas countries, and the research and development of the vaccine has entered the sprint phase and is ready for mass production.

  • Nov
    28
    [2014] [TECHNOLOGY INFORMATION] BUTYL RUBBER PLUG INDUSTRY EXPANDING SCIENTIFIC RESEARCH FIELD

    国内外丁基橡胶塞行业的研发最新进展主要有以下几方面: 1.超洁净橡胶、专用材料及配方和工艺的研究。这些研究主要是保证满足某些特殊敏感药品,如部分化学和生物活性敏感的头孢粉针制剂、酸碱性较强的输液制剂以及成分复杂的中药制剂的质量要求。从丁基橡胶塞的配方来看,生胶及一部分辅料属于脂溶性物质,其中也可能含有低分子物质,如果这些物质在生产胶塞过程中残留较多,封装药品后,就可能进入药品并发生物理吸附,导致水溶性药物的溶解性下降,出现澄清度下降甚至浑浊。所以选择超洁净的橡胶以及简单洁净的硫化系统,采用稳定有效的生产设备和工艺,从而生产出符合更多药物要求的洁净胶塞。 2.覆膜、镀膜或涂膜胶塞研究是指在胶

  • Nov
    25
    [2014] Overview of Safety Characteristics of Film-coated Rubber Plug Film

    覆膜胶塞膜材的安全特性概况时间:2014-11-25 15:55:24来源:中国医药包装协会 [中国]自2005年淘汰天然胶塞至今将近10年,中国的药用胶塞行业有了长足的发展,为医药工业做出了应有的贡献。药用胶塞类产品品种上也发生了很大变化,从最初的卤化丁基胶塞到现在的覆膜胶塞。虽然中国药用胶塞,特别是覆膜胶塞在近年来取得很大发展,但在实际的生产、申报及使用时,仍面临一些实际困难。为了能在满足胶塞和覆膜膜材安全性的基础上,使得覆膜胶塞品种得到健康的发展,以满足国内药品市场的实际需求,现将覆膜胶塞的应用情况及其膜材的安全特性进行概括。 一、覆膜胶塞的概念覆膜胶塞是指在胶塞(裸塞)与药物接触面的局

Follow us

Sweep swept away